Comment from Center on Reproductive Health, Law, and Policy
AnonymousSupportAcademic
Summary: A group of adolescent health researchers and clinicians argue that mifepristone is safe and effective for use by minors, citing clinical data and pharmacological evidence. They urge the FDA to ensure the medication remains accessible without age-based restrictions or regulations.
We submit this comment to provide context on the safety and efficacy of mifepristone in minor adolescents.